Table 1.
Scenarios for the uptake rates of medical therapies in Turkish population
| Baseline scenario (uptake rates in 2012) | Conservative scenario targets | Feasible scenario targets | Optimal scenario targets | |
|---|---|---|---|---|
| Acute stroke treatment | ||||
| Thrombolysis | 0,01 | 0,011 | 0,05 | 0,13 |
| Aspirin | 0,50 | 0,55 | 0,70 | 0,85 |
| Stroke unit | 0,00 | 0,01 | 0,40 | 0,85 |
| Secondary prevention | ||||
| Aspirin | 0,26 | 0,29 | 0,50 | 0,81 |
| Statin | 0,48 | 0,53 | 0,70 | 0,80a |
| Warfarin | 0,14 | 0,20 | 0,40 | 0,50a |
| BP control | 0,35 | 0,39 | 0,50 | 0,62 |
| Smoking cessation | 0,30 | 0,33 | 0,50 | 0,60a |
| Primary prevention | ||||
| BP control | 0,07 | 0,08 | 0,10 | 0,12a |
| HbA1c control | 0,49 | 0,54 | 0,70 | 0,80a |
| Smoking cessation | 0,04 | 0,07 | 0,10 | 0,13 |
| Warfarin | 0,30 | 0,33 | 0,50 | 0,78 |
aAssuming 10 % relative increase in scenarios